-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group’s AI Anchor “On Duty” Attracts Attention
Category:
发布时间：2025-02-27
【概要描述】
On February 25, Shisiyao’s Employee e-Home video channel welcomed a special “new employee”—the AI-powered virtual anchor “Chenxi,” which officially went live. Dressed in professional attire and wearing a warm smile, this AI anchor delivers smooth, engaging broadcasts and interactive experiences, injecting fresh digital vitality into the company’s promotional efforts. On its debut day, the channel garnered more than 7,000 views, quickly becoming a “phenomenal” innovation in corporate publicity that has sparked widespread discussion both within and outside the industry.
On February 25, the Shisiyao Employees’ E-Home video channel welcomed a special “new employee”—the AI-powered virtual anchor “Chenxi,” which officially went live. Dressed in professional attire and wearing a warm smile, this AI anchor delivers smooth, engaging broadcasts and interactive experiences, injecting fresh digital vitality into the company’s promotional efforts. On its debut day, the video garnered more than 7,000 views, quickly becoming a “phenomenal” innovation in corporate publicity that has sparked widespread discussion both within and beyond the industry.
“When we first received the assignment to develop an AI anchor, we didn’t even know what a large-scale deep-learning model was,” admitted an e-Jia video editor from Shisi Pharmaceutical Group. In response to the group’s mandate to fully leverage new AI technologies, the publicity team under the Party and Mass Work Department embarked on a cross-disciplinary learning journey to explore how best to use large-model technology to tell the story of Shisi Pharmaceutical. They actively participated in AI-tech training sessions organized by the company while also seeking guidance from IT specialists, diligently studying, experimenting, and refining their approach. After more than ten days of technical “building” and dozens of voice-synthesis tests, they ultimately developed an AI “anchor” capable of accurately delivering corporate news and updates.
“We’re only at the beginning of this journey. Our next step is to leverage technological upgrades to enable semantic analysis that automatically extracts key news points and generates broadcast scripts, thereby accelerating the dissemination of the latest updates on our company’s development while continuously enhancing both our professional expertise and approachability,” said an e-Jia video editor at Shisiyao Group. Looking ahead, the team plans to further empower the AI “anchor” with more online Q&A capabilities, ensuring timely delivery of richer, more up-to-date corporate information and fostering greater engagement. “Chenxi” is the first AI “female anchor” we’ve created, and the inaugural AI male “anchor” will soon be launched to meet our audience as well.
On the day of “Chenxi’s” debut, the Shisiyao Employee e-Home video channel released two corporate news reports: “Shijiazhuang Four Pharmaceutical Group’s Piribedil API Approved” and “Shijiazhuang Four Pharmaceutical Group Launches New Products—Tranexamic Acid Tablets and Acipimox Capsules Both Approved on the Same Day.” This visually engaging, integrated “technology + content” promotional approach sparked an enthusiastic response. Following the video’s release, group employees eagerly liked and shared it, a peer from a major pharmaceutical company even called specifically to inquire, and a media colleague commented enthusiastically: “The people at Four Pharmaceutical are keeping pace on the path of innovation.”
“The AI ‘anchor’ is not merely a virtual persona; it is the tangible embodiment of the company’s innovative DNA,” said the group’s head of corporate communications. “We will continue to advance our ‘smart-system-based publicity’ initiative, leveraging innovative thinking and cutting-edge technological applications to write a new chapter in the company’s high-quality development.”
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091